IL13RA2 and glioblastoma: CAR T cells can target glioblastoma-specific antigens, including interleukin-13 receptor subunit alpha-2 (IL-13Rα2), EGFR wt, and EGFRvIII, and are thus effective against glioblastoma in preclinical models [13,91,92].